Monday, 02 October 2017 by Rose-Marie Brandwein
One of this year’s most significant medical advances involves detecting the progress of cancer through biomarkers in the blood. While solid tissue biopsies can pinpoint tumor size and activity within a specific area, noninvasive liquid biopsies can provide greater insight into the genetics of tumor cells taken from a blood sample. Typically, cancerous tumors shed
According to the World Cancer Research Fund, there were an “estimated 14.1 million newly diagnosed cancer cases worldwide in 2012, of these 7.4 million cases were in men and 6.7 million in women. This number is expected to increase to 24 million by 2035.” What is not commonly known is that the majority of these
Young adults and children suffering with leukemia and lymphoma now have hope as a new CAR-T Therapy Tisagenlecleucel, developed and manufactured by Novartis, has been recommended by an oncology advisory panel of The US Food and Drug Administration (FDA). Many experts believe CAR-T Therapy presents a paradigm shift in how we approach and treat cancer.
“I’m a zombie until I drink my coffee,” so say many coffee addicts who claim to not feel “alive” until they’ve had a coffee to start their day. A recent study in Annals of Internal Medicine found that drinking two to four cups of coffee reduces the likelihood of circulatory disease and cerebrovascular disease mortality.
Wednesday, 28 June 2017 by Rose-Marie Brandwein
The National Cancer Institute defines BRCA1 and BRCA2 as “human genes that produce tumor suppressor proteins. These proteins help repair damaged DNA and, therefore, play a role in ensuring the stability of the cell’s genetic material. When either of these genes mutates, or is altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired